FloradaptTM DGST
Natural health product licensed in Canada
- Licence holder
- Kaneka Americas Holding Inc, CA, USA
- NPN or DIN-HM
- 80094857
- Status
- Active licence
- Licence date
- 10 October 2019
- Revision date
- Not provided
- Form
- Liquide oral
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium longum subsp. longum Source : Cellule entière | 0.5 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : ATCC 53103 | 5 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 5 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Acide citrique, Benzoate de sodium, Maltodextrine, Sorbate de potassium, Fructooligosaccharides, Stéarate de magnésium, Inuline, Eau purifiée, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 1 year ; maximum: 11 years | 10 mL | 1 Tous les jours |
Uses authorised in Canada
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
- Précautions et mises en garde
If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. Stop use and consult a health care practitioner/health care provider/health care professional/ doctor/physician if symptoms of digestive upset (e.g. diarrhea) occur, worsen and/or persists beyond 3 days.
Source
Official Health Canada record, licence 80094857
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.